Precision BioSciences Presents Phase 1 PBGENE-HBV Trial Data At HBV Cure Symposium; Targets Chronic Hepatitis B

TradingKey - As investors shift gears from solid performance from US equity for yet another year, focus is turning to predictions on performance for the Vanguard ETF in 2026 relative to overall market performance.

TradingKey - The semiconductor sector has been experiencing a massive rally recently, with Nvidia reaching an all-time high in terms of stock price. As of April 27, this chip manufacturer's market cap is now above $5 trillion with an impressive financial performance for its year ended 1-25-2026. Dur

NVIDIA isn’t simply a “chip maker” anymore; it is the lord of the AI age. Whether you are a growth investor or a value seeker looking at its forward P/E of ~42x, NVDA stock is a wager on the ongoing growth of human and artificial intelligence.

Palantir reports Q1 2026 earnings May 4 after close. Consensus: $1.54B revenue, $0.28 EPS. Polymarket 96% beat odds. Triangle breakout targets $153–$165. Buy or wait?

TradingKey - An athleisure company, Lululemon Athletica（LULU）, has built a very successful niche in the fashionable athletic wear category.